Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oculis Holding (OCS)
NASDAQ:OCS
Oculis Holding (OCS) Stock Price & Analysis
28 Followers
OCS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.05 - $14.50
Previous Close$12.16
Volume1.36K
Average Volume (3M)41.82K
Market Cap
$442.72M
Enterprise Value$346.30M
Total Cash (Recent Filing)$91.65M
Total Debt (Recent Filing)$605.00K
Price to Earnings (P/E)-6.5
Beta0.17
Next Earnings
May 08, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding36,649,705
10 Day Avg. Volume29,437
30 Day Avg. Volume41,816
Standard Deviation0.16
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)5.43
Price to Sales (P/S)504.71
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit392.19
Enterprise Value/Ebitda-930.00
Forecast
1Y Price Target
$27.00Price Target Upside124.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Oculis Holding News
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentBlockbuster potential for OCS-01 as a non-invasive treatment option for diabetic macular edema.
Financial StabilityExtended cash runway into the second half of 2026, providing financial stability for continued research and development.
Market OpportunityDry eye affects a significant population with many patients unsatisfied with current treatments, highlighting a large market for OCS-02.
Bears Say
Drug DevelopmentOn negative data for a drug candidate, the stock could go down as investors adjust the valuation and lower expectations.
EarningsNet loss totaled higher than the estimated loss.
Product CommercializationQuestions regarding the company's ability to effectively commercialize products and reach medical professionals could impact stock performance.
---
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
5.82% Other Institutional Investors
94.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
OCS FAQ
What was Oculis Holding’s price range in the past 12 months?
Oculis Holding lowest stock price was $9.05 and its highest was $14.50 in the past 12 months.
What is Oculis Holding’s market cap?
Currently, no data Available
When is Oculis Holding’s upcoming earnings report date?
Oculis Holding’s upcoming earnings report date is May 08, 2024 which is 7 days ago.
How were Oculis Holding’s earnings last quarter?
Oculis Holding released its earnings results on Mar 18, 2024. The company reported -$0.375 earnings per share for the quarter, beating the consensus estimate of -$0.45 by $0.075.
Is Oculis Holding overvalued?
According to Wall Street analysts Oculis Holding’s price is currently Undervalued.
Does Oculis Holding pay dividends?
Oculis Holding does not currently pay dividends.
What is Oculis Holding’s EPS estimate?
Oculis Holding’s EPS estimate is -$0.4.
How many shares outstanding does Oculis Holding have?
Oculis Holding has 36,740,295 shares outstanding.
What happened to Oculis Holding’s price movement after its last earnings report?
Oculis Holding reported an EPS of -$0.375 in its last earnings report, beating expectations of -$0.45. Following the earnings report the stock price went down -3.314%.
Which hedge fund is a major shareholder of Oculis Holding?
Among the largest hedge funds holding Oculis Holding’s share is Saba Capital Management. It holds Oculis Holding’s shares valued at N/A.
---
Oculis Holding Stock Smart Score
Company Description
Oculis Holding
European Biotech Acquisition Corp is a blank check company.
---
OCS Stock 12 Month Forecast
Average Price Target
$27.00
▲(124.07% Upside)
Technical Analysis
Best Analysts Covering OCS
1 Year
1 Year Success Rate
7/8 ratings generated profit
1 Year Average Return
+4.44%
reiterated a buy rating 3 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +4.44% per trade.
---